Abstract
BackgroundIncreasing evidence suggests the feasibility of biologic DMARD tapering in RA patients after achieving and maintaining good control of disease activity. Current guidelines on RA treatment also recommend tapering of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
